Consequently, administration of pharmaceutical agents that agonize MC4R cause weight loss by suppressing energy intake and stimulating energy expenditure, whereas genetic or pharmacological inhibition of MC4R results in hyperphagia and obesity. This evidence concerns the gene MC4R and obesity due to melanocortin 4 receptor deficiency.